Anastasia Bekpergenova

Mrs. Anastasia Bekpergenova

Ph.D, Researcher at the Laboratory of Infectious symbiology
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2021 in Asian Journal of Andrology
Verified
Journal Article
Open access
OBOleg V Bukharin
Oleg V Bukharin
NPNatalya B Perunova
Natalya B Perunova
EIElena V Ivanova
Elena V Ivanova
ICIrina N Chaynikova
Irina N Chaynikova
ABAnastasia Bekpergenova
Anastasia Bekpergenova
MKMichael D Kuzmin
Michael D Kuzmin
In this study, we determined the levels of cytokine secretory inhibitors and the microbiota biofilms of semen from healthy and infertile subjects. A total of 118 clinical bacterial isolates were isolated and tested. Cytokine secretory inhibitors were determined based on the difference in cytokine content between the control and experimental samples of cell-free supernatants of isolated microorganisms. Biofilm formation was studied by determining the adhesion of microorganisms to the surface of a 96-well sterile plate and expressed as the optical density at 630 nm (OD630). Cell-free supernatants ofStaphylococcuscontained higher levels of secretory inhibitor of cytokines in conditionally healthy than in infertile patients. In contrast, in infertile men, the ability to reduce cytokine levels was more characteristic ofEnterococcusandCorynebacterium. SeminalStaphylococcus,Corynebacterium, andEnterococcusisolated from infertile subjects showed a greater ability to form biofilms than the same bacteria isolated from healthy men. Further research is needed on this topic, since it is necessary to determine the relationships between decreased secretory inhibitors of cytokines, production of biofilms by bacteria in semen, and infertility. It is likely that the ability of microorganisms to change the concentration of cytokines and increase the level of biofilm formation in semen may be associated with minimal impairments of fertilizing ability, which are not detected using other methods.

25 June 2025 in Biological Products. Prevention, Diagnosis, Treatment
Verified
Journal Article
Open access
PDF file
Natalia Borisovna PerunovaNatalia Borisovna Perunova
Natalia Borisovna Perunova
OBO. V. Bukharin
O. V. Bukharin
ЕИЕлена Иванова
Елена Иванова
ABAnastasia Bekpergenova
Anastasia Bekpergenova
TBT. A. Bondarenko
T. A. Bondarenko
INTRODUCTION. An active search for probiotic strains of microorganisms, particularly indigenous bifidobacteria, is crucial for the development of therapeutic and prophylactic probiotics. Evaluating the probiotic potential of candidate strains requires their assessment for bacterial viability, antibiotic sensitivity, gastrointestinal stress tolerance, lysozyme resistance, and biofilm formation capacity.AIM. This study aimed to characterise a composition of indigenous Biffdobacterium strains, B. biffdum ICIS-310 and B. longum ICIS-505, as a potential probiotic product.MATERIALS AND METHODS. The study tested B. biffdum ICIS-310 and B. longum ICIS-505 for resistance to antibiotics, gastric acid, and bile. Mono- and co-cultures of B. biffdum ICIS-310 and B. longum ICIS-505 were tested for the number of viable cells during culture, antilysozyme activity (lysozyme resistance), and biofilm formation capacity. Antagonistic activity was tested against test strains of bacteria and fungi, including Candida albicans ATCC 24433, Proteus mirabilis ATCC 29906, Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 25922, Shigella flexneri ATCC 12022, and Klebsiella pneumoniaе ICIS-278_PBV. The content of acetic acid in the culture medium was determined by gas–liquid chromatography.RESULTS. The indigenous strains, B. biffdum ICIS-310 and B. longum ICIS-505, were selected according to the criteria of abundance, lysozyme resistance, and biofilm formation. These strains were found to lack pathogenicity genes, exhibit resistance to a number of antimicrobials (benzylpenicillin, streptomycin, and erythromycin), and remain viable in the presence of bile for 2 hours and in the presence of gastric acid for 30 minutes. The study demonstrated the biocompatibility of Biffdobacterium cultures, with the composition of B. biffdum ICIS-310 and B. longum ICIS-505 having a higher microbial cell count after 48 hours than monocultures. When co-cultured, B. biffdum ICIS-310 and B. longum ICIS-505 demonstrated a synergistic effect, resulting in increased lysozyme resistance (up to 2.2±0.30 μg/mL×OD450), biofilm formation (up to 0.89±0.20 OD630 units), and acetate production (up to 33.2 mM/L). The antagonistic activity against test strains was more pronounced in the co-culture than in the monocultures, with the respective growth inhibition zones of 30–36 mm and 18–24 mm.CONCLUSIONS. Indigenous B. biffdum ICIS-310 and B. longum ICIS-505 have demonstrated resistance to antimicrobial agents, bile salts, and gastric acid. Co-culturing the strains has revealed a synergistic effect on their lysozyme resistance, biofilm formation capacity, and antagonistic activity. The strains of bifidobacteria and the composition thereof hold promise for the development of novel probiotics. The evaluation of lysozyme resistance and biofilm formation capacity, as indicators of the adaptive potential of the microbiota, may be recommended for the selection and testing of probiotic strains.

8 November 2018 in Microbiology Resource Announcements
Verified
Journal Article
Open access
PDF file
Sergey AndryuschenkoSergey Andryuschenko
Sergey Andryuschenko
ЕИЕлена Иванова
Елена Иванова
Natalia Borisovna PerunovaNatalia Borisovna Perunova
Natalia Borisovna Perunova
IZIrina A. Zdvizhkova
Irina A. Zdvizhkova
ABAnastasia Bekpergenova
Anastasia Bekpergenova
OBOleg V. Bukharin
Oleg V. Bukharin
This report describes the draft genome sequence of Bifidobacterium bifidum strain ICIS-310, isolated from the feces of a healthy 5-year-old child from Orenburg, Russia. The size of the genome was 2,219,632 bp (62.4% G+C content).

28 July 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
ЕИЕлена Иванова
Елена Иванова
EDE. I. Danilova
E. I. Danilova
ICI. N. Chainikova
I. N. Chainikova
OCO. E. Chelpachenko
O. E. Chelpachenko
SFS. B. Fadeev
S. B. Fadeev
ABAnastasia Bekpergenova
Anastasia Bekpergenova
Introduction. The role of the respiratory tract microflora violations as an etiological and pathogenetic factor in the development of the inflammative upper respiratory tract disease is indisputable, and the importance of persistence factors of respiratory opportunistic microorganisms (URT) is high. The traditional use of antibiotics and antimycotic agents in the pathology of URT has failed due to a significant increase in the number of antibiotic-resistant strains of microorganisms and the development of a number of undesirable adverse reactions in patients. An alternative advantage in these conditions is belonged to herbal preparations.Aim. To conduct a comparative in vitro study of antibacterial and antifungal activities of the plant essential oils as a component of the Dyshi Oil composition and the Dyshi Oil composition itself against opportunistic microorganisms - causative agents of inflammatory upper airway diseases.Materials and methods. Essential oils of clove, juniper, peppermint, eucalyptus, as well as the composition of oils “Dyshi” were used in the work. Staphylococcus aureus ATCC 25923, Klebsiella pneumoniae ICIS-278, Pseudomonas aeruginosa ATCC 27853, and Candida albicans ATCC 24433 bacterial cultures were used as test cultures. Staphylococcus epidermidis 25 strain, isolated from a conditionally healthy person, was chosen as a representative of the URT normobiota. Antimicrobial activity of essential oils was determined by the method of diffusion in nutrient agar, MIC - by the method of serial dilutions.Results. The presence of zones of pronounced growth retardation of Staphylococcus aureus, Klebsiella and Pseudomonas, as well as yeast-like fungi was established when exposed to the composition of “Dyshi” oils, while separately used oils did not have a visible effect on the growth of bacteria and fungi, which indicates a synergistic interaction of the drug oils components.Conclusion. The presence of a synergistic antimicrobial effect of the “Dyshi” oil composition against opportunistic bacteria and yeast-like fungi of the genus Candida has been proven. The absence of an inhibitory effect on the growth of Staphylococcus epidermidis, which is a representative of the upper respiratory tract normobiota indicates a possible selective effect of “Dyshi” oil aimed at maintaining the colonization resistance of the URT biotope.

27 February 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
OCO. E. Chelpachenko
O. E. Chelpachenko
EDE. I. Danilova
E. I. Danilova
ICI. N. Chainikova
I. N. Chainikova
ABAnastasia Bekpergenova
Anastasia Bekpergenova
TBT. A. Bondarenko
T. A. Bondarenko
VSV. V. Sumenko
V. V. Sumenko
Introduction. The work includes the results of clinical and microbiological studies that determine the feasibility of using the herbal preparation EPS® 7630 for the treatment of rhinopharyngitis (RF) in children. The introduction provides a brief review of the literature data on the role of the microbial factor and the important contribution of dysbiotic disorders of the URT microflora in the development of the Russian Federation. The porpose of persistent properties of opportunistic microorganisms (UPM) is outlined: the ability to biofilm formation – BPO and inactivation of lysozyme – ALA as dysbiotic markers of RF, which create conditions for relapses and chronicity of the disease, reduce the effectiveness of antimicrobial therapy. Goal.The aim of the work was the clinical and microbiological substantiation of the effectiveness of using EPS® 7630 in the treatment of RF in children.Materials and methods. The study involved 79 children aged 3 to 15 years. 1st group – 43 children who received treatment, including, along with traditional treatment, the drug Umckalor EPS® 7630, 2nd group (comparison) – 36 children who did not receive the tested drug. Microbiological examination was carried out by taking swabs from the pharynx and nose before and after treatment; BPO and ALA were determined according to the methods of Bukharin O.V. et al. (1999).Results. Conducted clinical studies have established a reduction in the timing of relief of the main symptoms of RF (cough, rhinitis, sore throat, fever) in children treated with EPS® 7630 compared to the comparison group. Microbiological studies of microorganisms isolated from the nasopharynx of children with RF revealed the ability of EPS® 7630 to suppress bacterial persistence factors (BPO and ALA) by 60% or more from the initial level.Conclusions. The data obtained reveal one of the mechanisms of the antimicrobial action of EPS® 7630, which consists in suppressing the persistent potential of UPM and regulating the effect of the drug on the microbiocenosis of the URT. The clinical and microbiological efficacy of using EPS® 7630 in the treatment of RF in children has been proven.

1 January 2023 in Russian Clinical Laboratory Diagnostics
Verified
Journal Article
Open access
OCO E Chelpachenko
O E Chelpachenko
EDE I Danilova
E I Danilova
Natalia Borisovna PerunovaNatalia Borisovna Perunova
Natalia Borisovna Perunova
EIE V Ivanova
E V Ivanova
INI A Nikiforov
I A Nikiforov
TBT A Bondarenko
T A Bondarenko
Based on the clinical and microbiological monitoring of two groups of children aged 3 to 17 years with acute (n=78) and chronic (n=46) course of reactive arthritis (ReA), a method for early diagnosis of chronic arthritis was developed by determining the number of antibiotic-resistant coprostrains in patients with ReA, characterized by the absence of the need to isolate a pure culture of the pathogen and its identification; inoculation of faeces at a dilution of 10-5 on solid 1.5% GRM-agar with an antibacterial agents used in the treatment of a particular patient, at a minimum inhibitory concentration in the resistance range, followed by incubation and counting of the colonies of microorganisms grown on the plate. A significant relationship between the number of antibiotic-resistant gut bacterial strains and the course of arthritis (acute, chronic) was revealed, and the borderline value of the number of antibiotic-resistant gut bacterial strains was determined - 5×103 CFU/g, which allows differentiating the acute course from the chronic one: in the acute course< 5×103 CFU/g, with chronic - ≥ 5×103 CFU/g. The method allows, at the stage of completion of anti-inflammatory therapy in the active phase of the disease, to identify a risk group for the development of a chronic course of arthritis among patients with ReA, which can contribute to timely therapeutic measures aimed at preventing recurrence of the disease and making the patient disabled.